These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25633037)

  • 1. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter.
    Giorgi Rossi P; Fortunato C; Barbarino P; Boveri S; Caroli S; Del Mistro A; Ferro A; Giammaria C; Manfredi M; Moretto T; Pasquini A; Sideri M; Tufi MC; Cogo C; Altobelli E;
    Br J Cancer; 2015 Feb; 112(4):667-75. PubMed ID: 25633037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials.
    Verdoodt F; Jentschke M; Hillemanns P; Racey CS; Snijders PJ; Arbyn M
    Eur J Cancer; 2015 Nov; 51(16):2375-85. PubMed ID: 26296294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
    Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
    J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland.
    Virtanen A; Anttila A; Nieminen P
    BMC Womens Health; 2015 Nov; 15():99. PubMed ID: 26542953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
    Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Self-sampling and reminder letters increase participation in the Finnish cervical cancer screening programme].
    Virtanen A; Nieminen P; Malila N; Luostarinen T; Anttila A
    Duodecim; 2013; 129(16):1709-17. PubMed ID: 24069641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
    Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
    BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial.
    Virtanen A; Nieminen P; Luostarinen T; Anttila A
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1960-9. PubMed ID: 21752985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial.
    Haguenoer K; Sengchanh S; Gaudy-Graffin C; Boyard J; Fontenay R; Marret H; Goudeau A; Pigneaux de Laroche N; Rusch E; Giraudeau B
    Br J Cancer; 2014 Nov; 111(11):2187-96. PubMed ID: 25247320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening.
    Darlin L; Borgfeldt C; Forslund O; Hénic E; Hortlund M; Dillner J; Kannisto P
    J Clin Virol; 2013 Sep; 58(1):155-60. PubMed ID: 23867008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland.
    Virtanen A; Anttila A; Luostarinen T; Nieminen P
    Int J Cancer; 2011 Jun; 128(11):2681-7. PubMed ID: 20669228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ESSAG-trial protocol: A randomized controlled trial evaluating the efficacy of offering a self-sampling kit by the GP to reach women underscreened in the routine cervical cancer screening program.
    Gezels E; Van Roy K; Arbyn M; Coursier P; Devroey D; Martens P; Simoens C; Vaes B; Van Herck K; Vankrunkelsven P; Verhoeven V; Willems S
    Contemp Clin Trials; 2024 Sep; 144():107617. PubMed ID: 38977179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.
    Winer RL; Tiro JA; Miglioretti DL; Thayer C; Beatty T; Lin J; Gao H; Kimbel K; Buist DSM
    Contemp Clin Trials; 2018 Jan; 64():77-87. PubMed ID: 29113956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program.
    Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R
    Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia.
    Veerus P; Hallik R; Jänes J; Jõers K; Paapsi K; Laidra K; Innos K
    J Med Screen; 2022 Mar; 29(1):53-60. PubMed ID: 34694179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the effectiveness of cervical cancer screening invitation letters.
    Decker KM; Turner D; Demers AA; Martens PJ; Lambert P; Chateau D
    J Womens Health (Larchmt); 2013 Aug; 22(8):687-93. PubMed ID: 23915107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.